Co-founders behind pioneering Covid vaccine to step down from BioNTech
Uğur Şahin and Özlem Türeci are leaving German group to launch their own mRNA venture
Related reading
BioNTech to cut fifth of workforce as it winds down Covid vaccine production
German biotech is shifting towards cancer treatments
BioNTech settles Covid-19 patent dispute with CureVac
UK’s GSK will receive $370mn and 1% of sales of some vaccines as part of the deal
US vaccine overhaul unnerves investors as sceptics seize advisory posts
Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments
Merck nears deal for flu-prevention biotech Cidara
San Diego company’s lead drug is a potential alternative to vaccines for vulnerable patients
UK biotech keeps selling itself to America
A shortage of late-stage capital pushes the biggest prizes into US hands
America’s unfortunate backward step on vaccines
2025 has been a good year for immunisation science, but not in the US